Syntara Ltd (ASX:SNT)
A$ 0.033 -0.001 (-2.94%) Market Cap: 42.59 Mil Enterprise Value: 39.30 Mil PE Ratio: 0 PB Ratio: 8.25 GF Score: 0/100

Pharmaxis Ltd Corporate Presentation Transcript

May 24, 2023 / NTS GMT
Release Date Price: A$0.05 (-9.09%)
Unidentified Participant

Presentation
May 24, 2023 / NTS GMT

=====================
Corporate Participants
=====================
* Gary Phillips
Pharmaxis Ltd - CEO

=====================

Gary Phillips
Pharmaxis Ltd - CEO

Good morning, everyone. The clock has now just pass 9:00 AM. So we will get started with a special investor briefing with Pharmaxis' CEO, Gary Phillips, who has some very exciting clinical data to be presented from Pharmaxis skin scarring trials freshly analyzed over at the University of Western Australia. My name is Alfred, and I'm part of Pharmaxis' Investor Relations team, and I'll assist with running today's briefing. (Event Instructions)

Having been in a trading hope for the past couple of days, while data was being finalized, it's been a very busy days for Pharmaxis. And I'm sure Gary is very excited to present this new data. So Gary, I won't take up any of -- more of your time. Let me hand over to you.

-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot